INTRAVENOUS METHYLPREDNISOLONE VERSUS INTRAMUSCULAR ACTH IN THE TREATMENT OF ACUTE RELAPSES IN MULTIPLE-SCLEROSIS

被引:0
|
作者
不详
机构
来源
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1357 / 1357
页数:1
相关论文
共 50 条
  • [41] Peripheral blood cell immunomarkers in the course of methylprednisolone treatment of multiple sclerosis relapses
    Michalowska-Wender, Grazyna
    Wender, Mieczyslaw
    [J]. FOLIA NEUROPATHOLOGICA, 2008, 46 (02) : 134 - 138
  • [42] CURRENT TREATMENT OF MULTIPLE-SCLEROSIS - ARE THERE INDICATIONS FOR INTRAVENOUS IMMUNOGLOBULINS
    SCHMIDT, S
    HOHLFELD, R
    [J]. NERVENARZT, 1995, 66 (04): : 304 - 307
  • [43] Intravenous pulse methylprednisolone in the treatment of uveitis associated with multiple sclerosis
    Wakefield, D
    Jennings, A
    McCluskey, PJ
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2000, 28 (02): : 103 - 106
  • [44] INTRATHECAL METHYLPREDNISOLONE ACETATE IN MULTIPLE-SCLEROSIS TREATMENT - CLINICAL-EVALUATION
    MAZZARELLO, P
    POLONI, M
    PICCOLO, G
    COSI, V
    PINELLI, P
    [J]. ACTA NEUROLOGICA BELGICA, 1983, 83 (04) : 190 - 196
  • [45] METHYLPREDNISOLONE IN MULTIPLE-SCLEROSIS - A COMPARISON OF ORAL WITH INTRAVENOUS THERAPY AT EQUIVALENT HIGH-DOSE
    ALAM, SM
    KYRIAKIDES, T
    LAWDEN, M
    NEWMAN, PK
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (11): : 1219 - 1220
  • [46] THE INFLUENCE OF CYCLOPHOSPHAMIDE VERSUS METHYLPREDNISOLONE THERAPY ON BLOOD LYMPHOCYTE SUBPOPULATIONS IN MULTIPLE-SCLEROSIS
    WAJGT, A
    SZCZECHOWSKI, L
    MARCZEWSKA, E
    STRZYZEWSKA, L
    [J]. RECENT ADVANCES IN MULTIPLE SCLEROSIS THERAPY, 1989, 863 : 249 - 252
  • [47] LONG-TERM EFFECT OF ACTH TREATMENT OF RELAPSE IN MULTIPLE-SCLEROSIS
    HOOGSTRATEN, MC
    MINDERHOUD, JM
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1990, 82 (01): : 74 - 77
  • [48] Efficacy and safety of oral versus intravenous high-dose methylprednisolone in multiple sclerosis relapses, a randomized double blind trial (COPOUSEP)
    Le Page, E.
    Veillard, D.
    Laplaud, D.
    Wardi, R.
    Lebrun, C.
    Zagnoli, F.
    Wiertlewki, S.
    Deburghgraeve, V.
    Coustans, M.
    Edan, G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 53 - 53
  • [49] DOUBLE-BLIND RANDOMIZED TRIAL OF ACTH VERSUS DEXAMETHASONE VERSUS METHYLPREDNISOLONE IN MULTIPLE-SCLEROSIS BOUTS - CLINICAL, CEREBROSPINAL-FLUID AND NEUROPHYSIOLOGICAL RESULTS
    MILANESE, C
    LAMANTIA, L
    SALMAGGI, A
    CAMPI, A
    EOLI, M
    SCAIOLI, V
    NESPOLO, A
    CORRIDORI, F
    [J]. EUROPEAN NEUROLOGY, 1989, 29 (01) : 10 - 14
  • [50] Comparison of different durations of high-dose intravenous methylprednisolone regimes in moderate relapses of multiple sclerosis
    Eraksoy, M
    Yesilot, N
    Topcular, B
    Topcular, NS
    Akman-Demir, G
    Turan, N
    Ozcan, H
    [J]. MULTIPLE SCLEROSIS, 2005, 11 : S169 - S169